Insider Transactions in Q1 2024 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2024
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
5,783
-0.8%
|
$5,540,114
$958.88 P/Share
|
|
Mar 13
2024
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
14,217
-20.81%
|
$13,804,707
$971.82 P/Share
|
|
Mar 13
2024
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+22.65%
|
$7,980,000
$399.66 P/Share
|
|
Mar 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
358
-2.6%
|
$346,186
$967.5 P/Share
|
|
Mar 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$97,800
$978.23 P/Share
|
|
Feb 26
2024
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
1,020
-1.96%
|
-
|
|
Feb 26
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.86%
|
$992,000
$992.5 P/Share
|
|
Feb 26
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.83%
|
$413,000
$413.33 P/Share
|
|
Feb 26
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.66%
|
$990,000
$990.0 P/Share
|
|
Feb 26
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
854
-38.19%
|
$836,066
$979.25 P/Share
|
|
Feb 26
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
854
+27.64%
|
$333,914
$391.92 P/Share
|
|
Feb 23
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$492,500
$985.0 P/Share
|
|
Feb 23
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 22
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
3,000
-3.66%
|
$2,895,000
$965.0 P/Share
|
|
Feb 22
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+3.53%
|
$1,239,000
$413.33 P/Share
|
|
Feb 22
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.59%
|
$967,000
$967.65 P/Share
|
|
Feb 15
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
123,601
-13.36%
|
$117,791,753
$953.83 P/Share
|
|
Feb 15
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
172,723
+15.73%
|
$68,916,477
$399.66 P/Share
|
|
Feb 14
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
10,434
-3.03%
|
$9,849,696
$944.53 P/Share
|
|
Feb 09
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
24,941
-30.51%
|
$23,718,891
$951.68 P/Share
|
|
Feb 09
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
35,375
+30.1%
|
$13,301,000
$376.93 P/Share
|
|
Feb 09
2024
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
4,919
-4.76%
|
$4,682,888
$952.92 P/Share
|
|
Feb 09
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$477,500
$955.0 P/Share
|
|
Feb 09
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 08
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$472,500
$945.0 P/Share
|
|
Feb 08
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 07
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.53%
|
$950,000
$950.0 P/Share
|
|
Feb 07
2024
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
8,037
-2.02%
|
$7,635,150
$950.41 P/Share
|
|
Feb 05
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.76%
|
$934,000
$934.71 P/Share
|
|
Feb 02
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.17%
|
$268,636
$956.65 P/Share
|
|
Feb 02
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.64%
|
$151,200
$378.98 P/Share
|
|
Feb 02
2024
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
22,713
-27.44%
|
$21,713,628
$956.65 P/Share
|
|
Feb 02
2024
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
30,750
+27.09%
|
$12,269,250
$399.66 P/Share
|
|
Feb 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$95,200
$952.51 P/Share
|
|
Feb 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
273
-1.81%
|
$257,985
$945.61 P/Share
|
|
Jan 31
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-1.18%
|
$268,746
$953.42 P/Share
|
|
Jan 31
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.65%
|
$151,200
$378.98 P/Share
|
|
Jan 30
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
827
-37.44%
|
$793,093
$959.0 P/Share
|
|
Jan 30
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
827
+27.24%
|
$314,260
$380.95 P/Share
|
|
Jan 24
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.48%
|
$334,752
$951.26 P/Share
|
|
Jan 24
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.06%
|
$189,000
$378.98 P/Share
|
|
Jan 23
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-3.22%
|
$735,648
$948.5 P/Share
|
|
Jan 23
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.37%
|
$415,800
$378.98 P/Share
|
|
Jan 23
2024
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,569
-16.95%
|
$7,175,412
$948.5 P/Share
|
|
Jan 23
2024
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.28%
|
$4,770,000
$477.66 P/Share
|
|
Jan 23
2024
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,707
-29.78%
|
$2,571,650
$950.0 P/Share
|
|
Jan 23
2024
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,707
+22.95%
|
$1,691,875
$625.6 P/Share
|
|
Jan 17
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-1.52%
|
$329,928
$932.34 P/Share
|
|
Jan 17
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.1%
|
$189,000
$378.98 P/Share
|
|
Jan 12
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
568
-2.43%
|
$527,104
$928.18 P/Share
|